CoChat

Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma

Open access
Lynch, Fiona A, Katona, Lynda, Jefford, Michael, Smith, Allan Ben, Shaw, Joanne, Dhillon, Haryana M, Ellen, Steve, Phipps-Nelson, Jo, Lai-Kwon, Julia, Milne, Donna, Russell, Lahiru, Dax, Victoria, Diggens, Justine, Kent, Holly, Button-Sloan, Alison, Elliott, Jane, Shackleton, Mark, Burridge, Hayley, Ftanou, Maria · 2020 · Journal of Clinical Medicine
Cited by 42

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm9092969

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 42

Metadata

Authors
Lynch, F. A., Katona, L., Jefford, M., Smith, A. B., Shaw, J., Dhillon, H. M., Ellen, S., Phipps-Nelson, J., Lai-Kwon, J., Milne, D., Russell, L., Dax, V., Diggens, J., Kent, H., Button-Sloan, A., Elliott, J., Shackleton, M., Burridge, H., & Ftanou, M.
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2020-09-14
Volume
9
Issue
9
Pages
2969
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3086563989
Cited by
42
References
21
FWCI
2.09
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma. https://app.cochat.ai/papers/10.3390/jcm9092969
The paper
Lynch, F. A., Katona, L., Jefford, M., Smith, A. B., Shaw, J., Dhillon, H. M., Ellen, S., Phipps-Nelson, J., Lai-Kwon, J., Milne, D., Russell, L., Dax, V., Diggens, J., Kent, H., Button-Sloan, A., Elliott, J., Shackleton, M., Burridge, H., & Ftanou, M. (2020). Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma. Journal of Clinical Medicine. https://doi.org/10.3390/jcm9092969

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.